Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Outset Medical Sees Q2 2021 Net Revenue $24M-$25M

Outset announced that preliminary unaudited net revenue for the second quarter of 2021 is expected to be in the range of $24.5 million to $25.0 million, representing growth

byBenzinga Newsdesk

July 1, 2021

1 minute read

Outset announced that preliminary unaudited net revenue for the second quarter of 2021 is expected to be in the range of $24.5 million to $25.0 million, representing growth of 109% to 113% over Q2 of 2020.

Neurocrine Biosciences Shares Jump After Raising Ingrezza Sales Guidance

By Vandana Singh

Today, 6:04 AM

Tucked in its Q2 earning release, Neurocrine Biosciences Inc (NASDAQ:NBIX) said that in August, the Phase 2a study of NBI-827104…

NBIX

AT&T Wins $15M 11-Year Contract To Modernize Army National Guard Command, Control Network

By Benzinga Newsdesk

Today, 6:04 AM

What's the news? AT&T* was awarded a task order to modernize GuardNet, the command and control network that allows Army National Guard soldiers to access the Internet, connect with other networks and

B of A Securities Maintains Buy on Funko, Raises Price Target to $35

By Benzinga Newsdesk

Today, 6:04 AM

B of A Securities analyst Alexander Perry maintains Funko (NASDAQ:FNKO) with a Buy and raises the price target from $30 to $35.

FNKO

Sixth Street Specialty Q4 EPS $0.55 Beats $0.52 Estimate

By Benzinga Newsdesk

Today, 6:04 AM

Sixth Street Specialty (NYSE:TSLX) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.52 by 5.77 percent. This is a 10 percent increase over earnings of $0.50 per share from

TSLX

Outset Medical Sees Q2 2021 Net Revenue $24M-$25M

Related Posts

Neurocrine Biosciences Shares Jump After Raising Ingrezza Sales Guidance

AT&T Wins $15M 11-Year Contract To Modernize Army National Guard Command, Control Network

B of A Securities Maintains Buy on Funko, Raises Price Target to $35

Sixth Street Specialty Q4 EPS $0.55 Beats $0.52 Estimate